{"id":6008,"date":"2021-01-01T19:11:13","date_gmt":"2021-01-01T19:11:13","guid":{"rendered":"https:\/\/splmed.com\/?p=6008"},"modified":"2023-05-02T12:37:26","modified_gmt":"2023-05-02T12:37:26","slug":"head-to-head-comparison-of-68ga-prostate-specific-membrane-antigen-pet-ct-and-ferumoxtran-10-enhanced-mri-for-the-diagnosis-of-lymph-node-metastases-in-prostate-cancer-patients","status":"publish","type":"post","link":"https:\/\/splmed.com\/english\/head-to-head-comparison-of-68ga-prostate-specific-membrane-antigen-pet-ct-and-ferumoxtran-10-enhanced-mri-for-the-diagnosis-of-lymph-node-metastases-in-prostate-cancer-patients\/","title":{"rendered":"Head-to-head comparison of 68Ga-prostate-specific membrane antigen PET\/CT and ferumoxtran-10 enhanced MRI for the diagnosis of lymph node metastases in prostate cancer patients"},"content":{"rendered":"","protected":false},"excerpt":{"rendered":"<p>The goal of this first study comparing Nano-MRI (MRI with a ferumoxtran-10 contrast agent) and 68Ga PSMA- PET\/CT was to investigate a potential complementary role for these novel imaging modalities in identifying suspect lymph nodes in prostate cancer patients. Nano-MRI in a comparison with 68Ga-PSMA- PET\/CT identified significantly more suspected lymph nodes; at the same, nanoparticle-MRI appeared to be superior in detecting smaller suspicious LNs. Both methods seem to be complementary in their potential clinical use.<\/p>","protected":false},"author":1,"featured_media":6009,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[6],"tags":[],"class_list":["post-6008","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6008","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/comments?post=6008"}],"version-history":[{"count":2,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6008\/revisions"}],"predecessor-version":[{"id":6117,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/posts\/6008\/revisions\/6117"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media\/6009"}],"wp:attachment":[{"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/media?parent=6008"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/categories?post=6008"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/splmed.com\/english\/wp-json\/wp\/v2\/tags?post=6008"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}